Hyderabad-based Biological-E will reserve 30 crore of COVID-19 vaccine doses after the Indian government decided to make an advance payment to the vaccine manufacturer. These vaccine doses will be manufactured and stockpiled by Biological-E from August-December 2021. This has been undertaken as part of Government of India's ‘Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission’ which was launched to reinforce and accelerate COVID-19 vaccine development efforts, the government said. Separately, Biological E. has entered into a licensing agreement with Providence Therapeutics Holdings to manufacture the Canadian company's mRNA COVID-19 vaccine in India. Biological E also has a separate deal to produce about 60 crore doses of Johnson & Johnson's COVID-19 shot annually.

Source: Mint June 03, 2021 02:52 UTC